Skip to main content
. 2022 Sep 24;13(9):817. doi: 10.1038/s41419-022-05259-w

Fig. 3. Availability and utilization of glucose and glutamine to generate uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) in different states in pancreatic cells.

Fig. 3

A During resting, approximately 2–5% of cellular glucose enters the hexosamine biosynthesis pathway (HBP) to generate the end product UDP-GlcNAc. B During adaptation, high glucose induces genome instability through O-linked-N-acetylglucosaminylation (O-GlcNAcylation) of phosphofructokinase 1 (PFK1) and ribonucleotide reductase catalytic subunit M1 (RRM1) to direct glycolysis and the pentose phosphate pathway (PPP) into the HBP. C During hyperproliferation, such as in pancreatic cancer cells, both high glucose and high glutamine are required through overactivation/overexpression of PFK1, shunting glycolysis into the PPP and HBP to generate energy and biosynthesis precursors to meet the needs of cancer cells. G6P glucose 6-phosphate, F6P fructose 6-phosphate, FBP fructose 1,6-phosphate, GFAT glutamine:fructose-6-phosphate amidotransferase, R5P ribose 5-phosphate, PRPP phosphoribosyl pyrophosphate, NDP nucleoside diphosphate, dNDP deoxynucleoside diphosphates, GlcN6P glucosamine-6-phosphate, UDP-GlcNAc uridine diphosphate-N-acetylglucosamine.